OA
BMY icon

Oxbow Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Oxbow Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-179,524
Closed -$9.68M – 252
2025
Q4 		$9.68M Buy
179,524
+35,740
+25% +$1.72M 0.85% 24
2025
Q3 		$6.48M Buy
+143,784
New +$6.72M 0.6% 37
2024
Q1 		– Sell
-76,201
Closed -$3.91M – 225
2023
Q4 		$3.91M Buy
+76,201
New +$4M 0.59% 46
2019
Q3 		– Sell
-23,152
Closed -$1.05M – 298
2019
Q2 		$1.05M Sell
23,152
-33,764
-59% -$1.57M 0.13% 150
2019
Q1 		$2.71M Buy
56,916
+3,065
+6% +$153K 0.33% 74
2018
Q4 		$2.8M Buy
53,851
+35,956
+201% +$1.93M 0.37% 60
2018
Q3 		$1.11M Buy
+17,895
New +$1.06M 0.13% 139
2017
Q2 		– Sell
-20,716
Closed -$1.13M – 239
2017
Q1 		$1.13M Buy
20,716
+581
+3% +$31.9K 0.18% 126
2016
Q4 		$1.18M Sell
20,135
-41,096
-67% -$2.25M 0.15% 129
2016
Q3 		$3.3M Sell
61,231
-2,961
-5% -$190K 0.45% 68
2016
Q2 		$4.72M Sell
64,192
-5,718
-8% -$404K 0.68% 42
2016
Q1 		$4.47M Sell
69,910
-5,158
-7% -$325K 0.63% 44
2015
Q4 		$5.16M Buy
75,068
+9,070
+14% +$599K 0.65% 45
2015
Q3 		$3.91M Sell
65,998
-8,127
-11% -$516K 0.64% 43
2015
Q2 		$4.93M Sell
74,125
-2,550
-3% -$168K 0.64% 42
2015
Q1 		$4.95M Buy
+76,675
New +$4.8M 0.74% 40
2014
Q2 		– Sell
-26,035
Closed -$1.35M – 217
2014
Q1 		$1.35M Sell
26,035
-7,995
-23% -$425K 0.2% 97
2013
Q4 		$1.81M Buy
34,030
+15,430
+83% +$786K 0.26% 92
2013
Q3 		$861K Sell
18,600
-550
-3% -$24.1K 0.14% 113
2013
Q2 		$856K Buy
+19,150
New +$831K 0.15% 101

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxbow Advisors's BMY Position: Q1 2026 in Review

Oxbow Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 179,524 shares — an estimated $9.68M sold.

Oxbow Advisors first reported a position in BMY in Q2 2013 and held it in 20 quarters. The position peaked at $9.68M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Oxbow Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Oxbow Advisors sold 179,524 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.68M.
  • Oxbow Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 20 quarters.
  • Oxbow Advisors's Bristol-Myers Squibb position peaked at $9.68M in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.